Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioDelivery Sciences International, Inc. (NASDAQ: BDSI).

Full DD Report for BDSI

You must become a subscriber to view this report.


Recent News from (NASDAQ: BDSI)

Midday Gainers / Losers (05/17/2018)
Gainers: CARV +78% . CPSH +40% . EGY +24% . EIGR +20% . LOXO +18% . BZUN +17% . BDSI +17% . RTTR +16% . ESND +15% . WWE +15% . More news on: Carver Bancorp, Inc., CPS Technologies Corp., VAALCO Energy, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 17 2018 12:40
Healthcare - Top 5 Gainers / Losers as of 12:20 AM (05/17/2018)
Gainers : LOXO +19% . RTTR +18% . SPPI +17% . EIGR +16% . BDSI +15% . More news on: Loxo Oncology, Ritter Pharmaceuticals, Spectrum Pharmaceuticals, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 17 2018 12:21
Premarket Gainers as of 9:05 am (5/17/2018)
BLNK +16% . More news on: Blink Charging Co., Minerva Neurosciences, Loxo Oncology, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 17 2018 09:19
Breakfast Technical Briefing on BioLine Rx and Three More Biotech Stocks
Stock Research Monitor: PETX, BCRX, and BDSI LONDON, UK / ACCESSWIRE / May 17, 2018/ If you want a free Stock Review on BLRX sign up now at www.wallstequities.com/registration . In today's pre-market research, WallStEquities.com evaluates Aratana Therapeutics Inc. (NASDAQ: PETX ), Bi...
Source: ACCESSWIRE IA
Date: May, 17 2018 09:00
BioDelivery Sciences prices convertible stock offering; shares ahead 18% premarket
Thinly traded micro cap BioDelivery Sciences (NASDAQ: BDSI ) is up  18%  premarket on average volume in response to the pricing for its $50M direct offering of Series B Non-Voting Convertible Preferred Stock to institutional investors. More news on: BioDelivery Sciences Interna...
Source: SeekingAlpha
Date: May, 17 2018 08:51
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
$50 Million Equity Financing Led By Broadfin Announced Separately Today Three New Independent Directors Selected by Broadfin Added To Board; Four Current Independent Directors Retiring Amends Senior Credit Facility with CRG, which Includes Pushing Out Principal Debt Repayment...
Source: GlobeNewswire
Date: May, 17 2018 08:01
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it has entered into definitive agreements with existing institutional and other accredited investors to purchase an aggregate of approximately $50 million worth of BDS...
Source: GlobeNewswire
Date: May, 17 2018 08:01
FDA OKs first non-opioid treatment for opioid withdrawal
The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read ...
Source: SeekingAlpha
Date: May, 16 2018 16:44
BioDelivery Sciences International, Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 11 2018 14:09
Reader Inquiry: At 52-Week Lows Is BioDelivery Sciences A Viable Turnaround Play?
Shares of BioDelivery Sciences International ( BDSI ) have lost three quarters of their value in the past three years and are also in the red by nearly 40% year to date. The changeup of leadership along with mention from a few members in ROTY brought this one back to my attention. Chart ...
Source: SeekingAlpha
Date: May, 11 2018 02:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-202.852.8252.902.755175,300
2018-08-172.802.8252.902.75129,153
2018-08-162.652.852.952.605663,965
2018-08-152.702.6252.752.55837,925
2018-08-142.702.6752.702.55508,286

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-201,96061,7243.1754Cover
2018-08-174,86542,68511.3974Cover
2018-08-1646,594360,36012.9298Cover
2018-08-15225,206279,63980.5345Short
2018-08-14155,830224,51769.4068Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BDSI.


About BioDelivery Sciences International, Inc. (NASDAQ: BDSI)

Logo for BioDelivery Sciences International, Inc. (NASDAQ: BDSI)

Not available

 

Contact Information

 

 

Current Management

  • Mark A. Sirgo / President, CEO
  • James A. McNulty / CFO, Secretary
  • Francis E. O Donnell Jr. / Chairman

Current Share Structure

  • Market Cap: $119,821,721 - 05/14/2018
  • Issue and Outstanding: 58,449,620 - 03/13/2018

 


Recent Filings from (NASDAQ: BDSI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 17 2018
Free Writing Prospectus
Filing Type: FWPFiling Source: edgar
Filing Date: May, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 01 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 18 2018

 

 


Daily Technical Chart for (NASDAQ: BDSI)

Daily Technical Chart for (NASDAQ: BDSI)


Stay tuned for daily updates and more on (NASDAQ: BDSI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BDSI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BDSI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BDSI and does not buy, sell, or trade any shares of BDSI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/